DK0712931T4 - Interferon-gamma-produktionsinducerende polypeptid, monoklonalt antistof og middel mod sygdomme, der responderer på interferon-gamma - Google Patents

Interferon-gamma-produktionsinducerende polypeptid, monoklonalt antistof og middel mod sygdomme, der responderer på interferon-gamma

Info

Publication number
DK0712931T4
DK0712931T4 DK95308055T DK95308055T DK0712931T4 DK 0712931 T4 DK0712931 T4 DK 0712931T4 DK 95308055 T DK95308055 T DK 95308055T DK 95308055 T DK95308055 T DK 95308055T DK 0712931 T4 DK0712931 T4 DK 0712931T4
Authority
DK
Denmark
Prior art keywords
interferon
gamma
agent
monoclonal antibody
inducing polypeptide
Prior art date
Application number
DK95308055T
Other languages
English (en)
Other versions
DK0712931T3 (da
Inventor
Kakuji Torigoe
Tadao Tanimoto
Shigeharu Fukuda
Masashi Kurimoto
Shimpei Ushio
Haruki Okamura
Toshio Kunikata
Mutsuko Taniguchi
Keizo Kohno
Original Assignee
Hayashibara Biochem Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27523434&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0712931(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from JP7058240A external-priority patent/JP2952750B2/ja
Priority claimed from JP7262062A external-priority patent/JP2724987B2/ja
Application filed by Hayashibara Biochem Lab filed Critical Hayashibara Biochem Lab
Application granted granted Critical
Publication of DK0712931T3 publication Critical patent/DK0712931T3/da
Publication of DK0712931T4 publication Critical patent/DK0712931T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK95308055T 1994-11-15 1995-11-10 Interferon-gamma-produktionsinducerende polypeptid, monoklonalt antistof og middel mod sygdomme, der responderer på interferon-gamma DK0712931T4 (da)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP30420394 1994-11-15
JP7058240A JP2952750B2 (ja) 1995-02-23 1995-02-23 モノクローナル抗体
JP7835795 1995-03-10
JP7262062A JP2724987B2 (ja) 1994-11-15 1995-09-18 インターフェロン−γの産生を誘導するポリペプチド
JP27498895 1995-09-29

Publications (2)

Publication Number Publication Date
DK0712931T3 DK0712931T3 (da) 2001-03-19
DK0712931T4 true DK0712931T4 (da) 2006-08-21

Family

ID=27523434

Family Applications (2)

Application Number Title Priority Date Filing Date
DK95308055T DK0712931T4 (da) 1994-11-15 1995-11-10 Interferon-gamma-produktionsinducerende polypeptid, monoklonalt antistof og middel mod sygdomme, der responderer på interferon-gamma
DK99104104T DK0962531T3 (da) 1994-11-15 1995-11-10 Interferon-gammaproduktion inducerende isoleret polypeptidfragment og et isolaret DNA-fragment der koder for dette polypeptid

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK99104104T DK0962531T3 (da) 1994-11-15 1995-11-10 Interferon-gammaproduktion inducerende isoleret polypeptidfragment og et isolaret DNA-fragment der koder for dette polypeptid

Country Status (7)

Country Link
EP (2) EP0962531B1 (da)
AU (1) AU700948B2 (da)
CA (1) CA2162353C (da)
DE (2) DE69535989D1 (da)
DK (2) DK0712931T4 (da)
ES (2) ES2156199T5 (da)
TW (2) TW581771B (da)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4004088B2 (ja) * 1995-09-26 2007-11-07 株式会社林原生物化学研究所 免疫担当細胞においてインターフェロン−γの産生を誘導する蛋白質
US7135458B1 (en) 1995-11-15 2006-11-14 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interferon-γ inducing polypeptide, pharmaceutical composition thereof, monoclonal antibody thereto, and methods of use
AU1341797A (en) * 1995-12-29 1997-07-28 Incyte Pharmaceuticals, Inc. Nucleic acids encoding interferon gamma inducing factor-2
JP2000511418A (ja) * 1996-05-20 2000-09-05 シェーリング コーポレイション ヒトインターロイキン―１ｊおよびそのアンタゴニスト
EP0816499A3 (en) * 1996-06-27 1999-10-27 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Genomic DNA encoding a polypeptide capable of inducing the production of interferon-gamma
US6790442B1 (en) 1996-06-27 2004-09-14 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Genomic DNA encoding a polypeptide capable of inducing the production of interferon-γ
JPH1080270A (ja) * 1996-07-19 1998-03-31 Hayashibara Biochem Lab Inc ポリペプチドをプロセッシングする酵素
TW515843B (en) * 1996-07-25 2003-01-01 Hayashibara Biochem Lab Process for producing an active polypeptide inducing interferon-γ production
JP4024366B2 (ja) * 1996-11-29 2007-12-19 株式会社林原生物化学研究所 ポリペプチド
US7141393B2 (en) 1996-12-26 2006-11-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interleukin-18-receptor proteins
JP3955352B2 (ja) 1997-02-25 2007-08-08 株式会社林原生物化学研究所 破骨細胞形成阻害剤
US6087116A (en) * 1997-03-12 2000-07-11 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interleukin-18 (IL-18) receptor polypeptides and their uses
DE69842119D1 (de) * 1997-08-07 2011-03-17 Toray Industries Methode zur herstellung von canine interleukin 18
EP1030681A4 (en) * 1997-11-03 2001-07-04 Wistar Inst METHOD AND COMPOSITIONS FOR INHIBITING ANGIOGENESIS AND TREATING CANCER
TWI227136B (en) * 1998-05-21 2005-02-01 Smithkline Beecham Corp Novel pharmaceutical composition for the prevention and/or treatment of cancer
AR022952A1 (es) 1999-03-19 2002-09-04 Smithkline Beecham Corp ANTICUERPO MONOCLONAL DE ROEDOR ESPECIFICAMENTE NEUTRALIZANTE PARA LA INTERLEUQUINA-18 HUMANA , UN FRAGMENTO FAB NEUTRALIZANTE o FRAGMENTO F(AB')2, UNA REGION DE COMPLEMENTARIEDAD DE CADENA LIGERA DE INMONOGLOBULINA(CDR), UNA MOLECULA DE ACIDO NUCLEICO, COMPOSICION FARMACEUTICA QUE LO COMPRENDE, EL
RU2175554C2 (ru) * 1999-03-30 2001-11-10 Пермское научно-производственное объединение "Биомед" Оральный препарат интерферона в виде таблеток
US6432678B1 (en) 1999-06-21 2002-08-13 Smithkline Beecham Corporation Macaca cynomolgus IL 18
KR100951067B1 (ko) 2000-02-10 2010-04-07 아보트 러보러터리즈 사람 인터류킨-18에 결합하는 항체 및 이를 제조하고사용하는 방법
GB0009503D0 (en) * 2000-04-17 2000-06-07 Univ Liverpool Screening method for compounds
HUP0302233A3 (en) * 2000-06-02 2006-11-28 Smithkline Beecham Corp Methods of treating viral diseases with il-18 and il-18 combinations
IL153422A0 (en) 2000-06-15 2003-07-06 Smithkline Beecham Corp Method for preparing a physiologically active il-18 polypeptide
NZ530765A (en) 2001-06-26 2006-11-30 Amgen Fremont Inc Antibodies that bind OPGL and compositions and methods for the treatment of bone diseases
AU2002365269A1 (en) * 2001-10-26 2003-07-24 Centocor, Inc. Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses
WO2004060911A2 (en) 2002-12-30 2004-07-22 Amgen Inc. Combination therapy with co-stimulatory factors
ATE459647T1 (de) 2003-04-15 2010-03-15 Glaxosmithkline Llc Humane il-18 substitutionsmutanten und deren konjugate
US7968684B2 (en) 2003-11-12 2011-06-28 Abbott Laboratories IL-18 binding proteins
US20050100965A1 (en) 2003-11-12 2005-05-12 Tariq Ghayur IL-18 binding proteins
EP2161032B1 (en) 2004-08-20 2011-09-28 GlaxoSmithKline LLC Healing of wounds by administering human IL-18
KR101416078B1 (ko) 2006-05-25 2014-07-07 글락소 그룹 리미티드 변형된 인간화 항­인터루킨­１８ 항체
PE20090190A1 (es) 2007-03-23 2009-03-22 Smithkline Beecham Corp Combinacion de anticuerpos anti-cd20 y polipeptidos de il-18
US8168165B2 (en) 2008-12-23 2012-05-01 Abbott Laboratories Alkylated interleukin-18 compositions
KR20120133382A (ko) 2010-02-09 2012-12-10 글락소 그룹 리미티드 대사 장애의 치료
US9376489B2 (en) 2012-09-07 2016-06-28 Novartis Ag IL-18 binding molecules
AU2015300006B2 (en) 2014-08-07 2018-08-30 Haruki Okamura Therapeutic agent for cancer which comprises combination of IL-18 and molecule-targeting antibody

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5457038A (en) * 1988-11-10 1995-10-10 Genetics Institute, Inc. Natural killer stimulatory factor
JP3230531B2 (ja) * 1991-08-08 2001-11-19 光信 佐藤 ＩＦＮ―γ誘導活性物質
DE69519454T2 (de) * 1994-07-14 2001-05-03 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo, Okayama Protein, das Interferon-Gamma Herstellung induziert und monoklonaler Antikörper dagegen

Also Published As

Publication number Publication date
AU700948B2 (en) 1999-01-14
EP0962531B1 (en) 2009-08-05
ES2156199T3 (es) 2001-06-16
DE69520088T2 (de) 2004-07-29
EP0712931A3 (en) 1997-03-26
DE69520088D1 (de) 2001-03-22
DE69535989D1 (de) 2009-09-17
TW464656B (en) 2001-11-21
ES2329099T3 (es) 2009-11-20
EP0712931B2 (en) 2006-04-19
EP0962531A3 (en) 1999-12-15
EP0962531A2 (en) 1999-12-08
DK0962531T3 (da) 2009-10-05
CA2162353C (en) 2010-04-27
AU3779695A (en) 1996-05-23
TW581771B (en) 2004-04-01
EP0712931B1 (en) 2001-02-14
CA2162353A1 (en) 1996-05-16
ES2156199T5 (es) 2006-12-16
DE69520088T3 (de) 2006-11-23
DK0712931T3 (da) 2001-03-19
EP0712931A2 (en) 1996-05-22

Similar Documents

Publication Publication Date Title
DK0712931T4 (da) Interferon-gamma-produktionsinducerende polypeptid, monoklonalt antistof og middel mod sygdomme, der responderer på interferon-gamma
NO980915D0 (no) Rekombinante anti-CD4-antistoff egnet for human terapi
NO910923D0 (no) Trifunksjonell antistofflignende forbindelse som et kombinert diagnostisk og terapeutisk middel.
DK0729951T3 (da) Naphthylforbindelser, mellemprodukter, præparater og fremgangsmåder
BR9504791B1 (pt) composto de polipeptìdeo e composição farmacêutica.
NO307707B1 (no) Spiroazabicykliske forbindelser, farmasøytisk preparat inneholdende slike forbindelser og anvendelse derav
NO894228D0 (no) Tienopyridiner, fremstilling, mellomprodukter og farmasoeytiske preparater.
DK597288A (da) Rekombinant, humant immunoglobulin og fremgangsmaade til fremstilling deraf
DK0605442T3 (da) Rekombinante antistoffer til human terapi
NO955167D0 (no) Monoklonalt anti-
DK101890D0 (da) Monoklonale antistoffer mod human interleukin-4 og hybridomaer, der producerer saadanne
NO891334L (no) Supraledende material og fremgangsmaate for dets fremstilling.
IS4466A (is) Samsetning og meðhöndlun fyrir heila- og mænusigg
DE3889062D1 (de) Monoklonaler Antikörper gegen humanen BCDF.
NO880434D0 (no) Anestetisk preparat og fremgangsmaate for bruk derav.
NO891006D0 (no) Terapeutisk aktivt polypeptid og fremgangsmaate for dets fremstilling.
NO995062L (no) <Beta>-anyloidpeptid-bindende proteiner og polynuldeotider som koder for samme
NO862920L (no) Onkofetale spesifikke monoklonale antistoffer, fremgangsmaate for fremstilling og anvendelse.
NO893892L (no) Antimikrobiologisk sammensetning og fremgangsmaate for anvendelse.
DK43489A (da) Immunotoksin og fremgangsmaade til dets fremstilling
DK8089D0 (da) Monoclonale antistoffer, deres fremstilling og anvendelse.
DK270386D0 (da) Monoklonalt antistof til humant protein c, dets fremstilling og anvendelse
DK31589D0 (da) Assay for begyndende diabetes, monoklonale antistoffer til anvendelse herved og saet til anvendelse hertil.
DK0391407T3 (da) Polypeptid og antibakterielle præparater, der indeholder det
DE69434900D1 (de) Menschliche chemokin-polypeptide